Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07263295
NA

Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine

Sponsor: Zhejiang University

View on ClinicalTrials.gov

Summary

The study aims to evaluation the effects of Liposomal Bupivacaine on diaphragmatic function in patients undergoing upper limb surgery who receive Interscalene Brachial Plexus Block. A total of 120 eligible patients will be enrolled and divided into two groups: Group A will receive 20ml of 0.5% Hydrochloride Bupivacaine , while Group B will receive 10ml of 0.5% Hydrochloride Bupivacaine plus 10ml of Liposomal Bupivacaine. Assessments of diaphragmatic function, pulmonary function, and pain intensity will be performed before the block and at different time points after the block, with follow-up for adverse events. The study is scheduled to run from September 2025 to September 2026, with strict adherence to privacy protection and ethical guidelines.

Official title: Evaluation of Diaphragmatic Function After Interscalene Brachial Plexus Block With Liposomal Bupivacaine: A Cohort Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-12-05

Completion Date

2026-12-20

Last Updated

2025-12-04

Healthy Volunteers

No

Interventions

DRUG

0.5% Hydrochloride Bupivacaine 20ml

0.5% Hydrochloride Bupivacaine 20ml for ISBPB

DRUG

0.5% Hydrochloride Bupivacaine 10ml

0.5% Hydrochloride Bupivacaine 10ml for ISBPB

DRUG

Liposomal Bupivacaine 10mL

Liposomal Bupivacaine 10mL for ISBPB

Locations (1)

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, zhejiang 310000

Hangzhou, Zhejiang, China